Excerpts

Similarly, in long-bone osteosarcomas, S1P 1 expression was associated with an increased risk of death HR = 1.29 (95% CI: 1.00–1.66) at the limit of significance (based on % of stained cells) with regard to overall survival.

With regard to long bones, the expression of GLUT-1 (% of stained cells and IRS score) was, associated with an increased risk of death HR = 1.16 (95% CI: 0.98–1.38) and HR = 1.14 (95% CI: 1.00–1.29) with borderline significance (0.08 and 0.06, respectively).

Abstract Simple Summary In recent years, there has been a clear trend toward personalized therapy procedures in patients with thyroid cancer with the aim to avoid unnecessary overtreatment of patients and to ensure an improved quality of life.

An increasing trend towards curative surgery has been witnessed in patients presenting with controlled PALN recurrence.

reported a slightly significant inverse correlation between SUV and ADC.

We found that in the tumor bulk, the change in F/B is now not quite significant in either RCB group, presumably due to the lower n produced by subdividing the patients, and in the tumor/stromal interface, any change in F/B remains insignificant in either RCB group ( Figure 4 ). 3.3.

Conclusions: There was a clear trend towards adjuvant BT for stage IA G3, stage IB, and stage II G1–2 LVSI-negative EC.

The slight, but statistically significant, increase in depressive symptoms and anxiety (and the nearly significant increase for stress) observed at T1 may have been due to sensitization and prolonged exposure to the pandemic.

Among them, CTNNB1 mutational status was the only one significantly associated to a shorter RFS (HR 2.62; 95% CI 1.14–6.02), and also showed a trend towards a worse OS (HR 2.17; 95% CI 0.81–5.78).

No evident separation between responding and non-responding classes can be visually highlighted, especially at low absorbed doses, while a weak trend toward a higher absorbed-dose tail for responding lesions is visible.

Of note, p53 expression has demonstrated no correlation with NAT response in contrast to gene studies [ 60 , 84 ], while borderline significance was demonstrated in van Olphen et al.

Essentially the same effect was found in both the multivariable analysis (10-year follow-up) and univariable analysis (25-year follow-up), but these findings were not strictly significant.

A positive and highly significant correlation was also observed between PAPPA and both IGF1 and IGF1R expression in bulk ILC ER+ tumors ( Supplementary Figure S6C ).

The data showing a highly significant improvement of local control obtained with LRHT and RT represent facts that we must consider as the basis for the further development of oncological hyperthermia and the correction of the problems with overall survival.

Furthermore, they found that having a germline mutation was associated with a significantly increased risk of prostate cancer metastases (varying from a nonsignificant relative risk (RR) for ATM mutation (RR: 1.6 (95% CI: 0.8–2.8) to highly significant for individuals with BRCA 2 mutations (RR: 26.7 (95% CI: 18.9–36.4)).

Supplementary Materials The following are available online at https://www.mdpi.com/article/10.3390/cancers14051254/s1 , Figure S1 Significant and possibly significant predictors of progression-free and overall survival for PDAC; Table S1: Perioperative clinical and pathological data. 40 DP CARs.xlsx; Table S2: Relative changes in the arterial geometry after DP CAR.xlsx; Table S3: Table for all PDAC 34 Appleby. xlsx; Table S4: Survival for 31 PDAC after Appleby.xlsx Table S5: Tumor size for PDAC.docx; File S1: Statistics 1 for PDAC survival.docx; File S2: Statistics 2 for PDAC survival.docx; File S3: Statistical analysis of hemodynamic changes after DPCAR.

Lower CBF also showed a trend for increased time to recurrence, despite not reaching statistical significance in a study by Qiao et al.

Surgical practices did not significantly differ, although there was a clear trend towards less minimally invasive surgery in the pandemic cohort (34.8% of cases vs. 48.1% in the pre-pandemic cohort).

showed a nonsignificant trend towards improved overall survival for adjuvant therapy (radiotherapy, chemotherapy, or both) in comparison to surgery without adjuvant therapy for patients with biliary tract cancers, including GBC (odds ratio [OR] 0.74; 95% CI, 0.55–1.01; p = 0.06) [ 86 ].

Indeed, a positive trend toward a better QoL was observed within patients receiving trifluridine/tipiracil [ 46 ].

The PERCIST criteria ( p = 0.059) showed marginally significant association with PFS.

p -values under 0.05 were considered significant and p -values between 0.05–0.1 were considered to indicate a statistical trend.

Model 3 constrains all pair correlations to be the same, and comparisons of the log-likelihoods with those of Model 1 show that there is highly significant evidence that this model is not consistent with the data; a similar statement applies to comparisons with Model 2.

In contrast, a small pilot randomized clinical trial of metformin in combination with first-line chemotherapy did not show a meaningful effect on progression-free survival, although a positive trend was observed and the negative modulation of the pro-tumor IGF-1 signaling axis was observed [ 72 ].

Metformin treatment showed a trend towards increased expression of 5-LOX and 15-LOX in tumors compared to the control at mRNA and protein levels ( Figure 10 C,D).